The price-to-book (P/B) ratio is widely favored by value investors for identifying low-priced stocks with exceptional returns. The ratio is used to compare a stock’s market value/price to its book ...

A healthy 9-year-old boy presented to our dermatology clinic for evaluation of a 2-year history of a bruise-like indurated plaque on his temple after a head-to-head collision with another child ...

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and ...

The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of ...

Plans to build 112 homes on land once occupied by Pfizer have been granted - but none of the properties will be classed as ...

Dhananjay Sinha, Co Head of Equities & Head of Research at Systematix Group, highlights the importance of a case-by-case ...

It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Scott Gottlieb, who served as commissioner of the Food and Drug Administration (FDA) during President-elect Trump’s first ...